Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

NCT00994760 · clinicaltrials.gov ↗
COMPLETED
Status
131
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda